MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0003390
Swati Spentose Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹205.55 Cr
▲ 11% YoY
Net profit · FY 2024
₹29.94 Cr
Net margin 14.6%
EBITDA · FY 2024
₹48.09 Cr
EBITDA margin 23.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.16 Cr
Issued & subscribed
Open charges
₹31.7 Cr
Satisfied ₹125.97 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
409
Provident fund records
About Swati Spentose Private Limited
Data last updated:
Swati Spentose Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2005PTC158176. Its GSTIN is 27AAJCS6271M1ZP (Maharashtra). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.16 Cr. It is led by directors including Manojkumar Rinwa and Pankaj Ram Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 114 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2024, the company reported a revenue of ₹205.55 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹29.94 Cr (net margin 14.6%) and EBITDA of ₹48.09 Cr (EBITDA margin 23.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 19% over five years.
The company has about 409 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Spentose. As per MCA filings, the company has open charges of ₹31.7 Cr and satisfied charges of ₹125.97 Cr on record. Court records list 31 cases involving the company, including 21 filed by the company and 10 filed against it; 8 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹15.69 Cr; the latest was in August 2021. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Vardhman Chemtech Limited with revenue of ₹208.69 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 1,493 overdue payments to 141 micro and small suppliers.
Swati Spentose Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0003390). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spentose.com.
Company details
CIN U51909MH2005PTC158176
Registration Number 158176
Incorporation Date 14 December 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0003390
Key People
Manojkumar Rinwa Director Pankaj Ram Sharma Director Vishal Narayanprasad Jajodia Director Recognitions & Rankings of Swati Spentose
Contact details
Swati Spentose Private Limited's registered office is in Mumbai, Maharashtra. Its website is spentose.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address114 Marine Chambers 11 New Marine Lines, Mumbai, Maharashtra, India – 400020
- IndustryPharma, API Manufacturers
To see the full contact details of Swati Spentose Private Limited, buy the company report.
Comprehensive company report
Swati Spentose Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Swati Spentose operates one associated brand: Spentose. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures pharmaceutical APIs and finished dosages for international markets. | spentose.com |
Business activity
The main business activities of Swati Spentose are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Swati Spentose Private Limited, buy the company report.
Financials of Swati Spentose Private Limited
FY 2024 filings availableSwati Spentose Private Limited reported revenue of ₹205.55 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹205.55 Cr ▲ 11%
Net profit · FY 2024
₹29.94 Cr margin 14.6%
EBITDA · FY 2024
₹48.09 Cr margin 23.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 14%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 4%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 11% growth in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.4% | ||||
| Net Profit Margin | 14.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swati Spentose Private Limited, buy the company report.
Board of directors of Swati Spentose Private Limited
Swati Spentose has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manojkumar Rinwa | Director | 07 Aug 2023 | 3 Years 2 Months | Current |
| Pankaj Ram Sharma | Director | 07 Aug 2023 | 3 Years 2 Months | Current |
| Vishal Narayanprasad Jajodia | Director | 20 Dec 2005 | 20 Years 10 Months | Current |
Peer comparison
Swati Spentose Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vardhman Chemtech Limited | ₹208.69 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| Aktinos Pharma Private Limited | ₹207.85 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India | |||
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | 30.0% | Aran Road, Ameerpet, Hyd-016, Telangana, India | |||
| Inogent Laboratories Private Limited | ₹206.9 Cr (FY 2017) | 18.0% | Hyderabad, Telangana, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Swati Spentose Private Limitedthis company | ₹205.55 Cr (FY 2024) | ₹29.94 Cr | 14.6% | 11.0% | 409 | Mumbai, Maharashtra, India |
| Sharon Bio-Medicine Limited | ₹204.22 Cr (FY 2025) | -20.0% | Panvel, Maharashtra, India | |||
| Orch Laboratories India Private Limited | ₹203 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Melody Healthcare Private Limited | ₹200.91 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| ZCL Chemicals Limited | ₹199.89 Cr (FY 2019) | 8.0% | Mumbai, Maharashtra, India | |||
| Shree Jee Laboratory Private Limited | ₹198.78 Cr (FY 2024) | -2.0% | New Delhi, Delhi, India |
To see the full peer comparison of Swati Spentose Private Limited, buy the company report.
Auditor
Swati Spentose Private Limited is audited by VINOD S MEHTA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINOD S MEHTA & CO | FY 2024 | 111524W |
Shareholding
The shareholding of Swati Spentose Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Swati Spentose Private Limited, buy the company report.
Charges & borrowings
Open charges
₹31.7 Cr
Satisfied charges
₹125.97 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jul 2023 | 100763594 | Hdfc Bank Limited | ₹1.7 Cr | Open | |
| 24 May 2022 | 100582067 | Standard Chartered Bank | ₹30 Cr | Open | |
| 17 Sep 2011 | 10316488 | Bank of Baroda | ₹14.85 Cr | Satisfied | |
| 05 Sep 2011 | 10309054 | Union Bank of India | ₹2.71 Cr | Satisfied | |
| 04 Jan 2011 | 10265350 | Union Bank of India | ₹3.8 Cr | Satisfied |
To see the full charge records of Swati Spentose Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Swati Spentose Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹15.69 Cr; the latest was in August 2021.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹15.69 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Secondary share transfer | Undisclosed | Seller: an individual |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Khimsar Impex Private Limited , Andhan Trade Link Private Limited, Hemang Fincap Services Private Limited |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Cubic Distribution Limited |
| Dec 2010 | Funding round | ₹15.69 Cr | Investors: Shivalik Ventures Private Limited , Karma Industries Limited , Alcon Biosciences Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Swati Spentose Private Limited has 31 court cases on record: 21 filed by Swati Spentose, 10 filed against it. 8 cases are pending and 23 are disposed.
Total cases
31
Filed by the company
21
Filed against the company
10
Pending
8
Disposed
23
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 3 | 4 |
| High courts | 10 | 7 | 2 |
| NCLAT | 4 | 0 | 2 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed against the company by Sartorius Stedim India Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against Shreerandal Interchem Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Shreerandal Interchem Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Molclone Labs Pvt Ltd and 2 others | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed by the company against Sartorius Stedim India Pvt Ltd and 1 other | Pending |
To see the full case history of Swati Spentose Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Swati Spentose Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 1,493 overdue payments to 141 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 141)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Dayaram Chemicals Private Limited | |||
| Meeraj Trading Corporation |
To see the full MSME payment records of Swati Spentose Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Swati Spentose has 2 subsidiary companies and 3 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
2
Subsidiary companies
3
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Kirti Speciality Private Limited | U24304GJ2020PTC112808 | |
| Swati Nova Laboratories Private Limited | U46497MH2023PTC411818 |
To see the full group structure of Swati Spentose Private Limited, buy the company report.
Employees & EPFO
Swati Spentose Private Limited has a workforce of 409 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
409
Active EPFO establishments
1
Employee growth
3.02%
GST
Swati Spentose has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCS6271M1ZP | Maharashtra | Active | 01 Jul 2017 |
| 05AAJCS6271M1ZV | Uttarakhand | Active | 01 Jul 2017 |
| 24AAJCS6271M1ZV | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Swati Spentose Private Limited, buy the company report.
Recent activity
Swati Spentose Private Limited has 8 board changes on record since 2005: 3 appointments and 5 cessations. The latest: Rakesh Ayodhyaprasad Pandey ceased to be Director on 07 Nov 2023.
AGM
Swati Spentose Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 17 Sep 2011 via Charge ID 10316488 with Bank Of Baroda was fully satisfied on 12 Aug 2024.
Charges
A charge registered on 05 Jun 2010 via Charge ID 10225719 with Bank Of Baroda was fully satisfied on 12 Aug 2024.
Charges
A charge with Standard Chartered Bank of Rs. 30.00 Cr registered on 24 May 2022 with Charge ID 100582067 was modified on 24 May 2024.
Filing
Swati Spentose Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Rakesh Ayodhyaprasad Pandey ceased to be Director.
Ceased
Manojkumar Rinwa ceased to be Additional Director.
Ceased
Pankaj Ram Sharma ceased to be Additional Director.
Appointed
Manojkumar Rinwa was appointed as Director.
Appointed
Pankaj Ram Sharma was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.70 Cr with Charge ID 100763594 was registered on 17 Jul 2023.
Charges
A charge with Standard Chartered Bank amounted to Rs. 30.00 Cr with Charge ID 100582067 was registered on 24 May 2022.
30 earlier events are in the company report.
Frequently asked questions
Swati Spentose is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 December 2005 (21+ years old) and is registered under CIN U51909MH2005PTC158176.
Swati Spentose has 3 current directors:
- Manojkumar Rinwa - Director
- Pankaj Ram Sharma - Director
- Vishal Narayanprasad Jajodia - Director
The latest financial statements of Swati Spentose on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Swati Spentose is 27AAJCS6271M1ZP, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 05AAJCS6271M1ZV (Uttarakhand), 24AAJCS6271M1ZV (Gujarat).
The CIN (Corporate Identification Number) of Swati Spentose is U51909MH2005PTC158176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swati Spentose has 31 court cases on record: 21 filed by the company and 10 filed against it. 8 are pending. Most are in the district courts.
Swati Spentose was incorporated on 14 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Swati Spentose has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹15.69 Cr; the latest was in August 2021.
The peers of Swati Spentose by revenue are Vardhman Chemtech Limited, Aktinos Pharma Private Limited, Nifty Labs Private Limited, Inogent Laboratories Private Limited, Smilax Laboratories Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rakesh Ayodhyaprasad Pandey ceased to be Director on 07 Nov 2023. Manojkumar Rinwa ceased to be Additional Director on 29 Sep 2023. Pankaj Ram Sharma ceased to be Additional Director on 29 Sep 2023. Swati Spentose has 8 board changes on record in total.
Yes, Swati Spentose is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0003390).
Swati Spentose has 13 MSME Form 1 returns on record between 2019 and 2024, listing 1,493 overdue payments to 141 micro and small suppliers. The latest return was filed on 30 Apr 2024.